NCT02735473View on ClinicalTrials.gov

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

September 10, 2021

Study Completion Date

September 10, 2021

Conditions
Fetal Alcohol Spectrum Disorders
Interventions
DRUG

Choline bitartrate

DRUG

Placebo

Trial Locations (1)

55454

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Minnesota

OTHER

NCT02735473 - Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders | Biotech Hunter | Biotech Hunter